Table 3.
Endpoints for thoracoscopic and catheter ablation
| Outcomes | Thoracoscopic ablation (N = 61) | Catheter ablation (N = 63) |
|---|---|---|
| All-cause mortality | 4 (7%) | 5 (8%) |
| Cardiovascular death | 1 (2%) | 4 (6%) |
| Non-cardiovascular death | 2 (3%) | 0 (0%) |
| Unknown cause of death | 1 (2%) | 1 (2%) |
| Myocardial infarction | 1 (2%) | 0 (0%) |
| Cerebrovascular eventa,b | 5 (8%) | 6 (10%) |
| Stroke | 4 (7%) | 2 (3%) |
| Transient ischaemic attack | 2 (3%) | 4 (6%) |
| Intracranial haemorrhage | 0 (0%) | 1 (2%) |
| Bleeding requiring transfusion or surgery | 0 (0%) | 1 (2%) |
| Permanent pacemaker implantation | 6 (10%) | 3 (5%) |
Outcomes are from the day of the procedure to last follow-up.
a
One patient in each group had both a transient ischaemic attack and stroke.
b
One patient in each group had a fatal cerebrovascular event and so are also included in the cardiovascular death outcome.